A machine learning approach to predicting risk of myelodysplastic syndrome.

Journal: Leukemia research
Published Date:

Abstract

BACKGROUND: Early myelodysplastic syndrome (MDS) diagnosis can allow physicians to provide early treatment, which may delay advancement of MDS and improve quality of life. However, MDS often goes unrecognized and is difficult to distinguish from other disorders. We developed a machine learning algorithm for the prediction of MDS one year prior to clinical diagnosis of the disease.

Authors

  • Ashwath Radhachandran
    Dascena, Inc., Houston, TX, United States.
  • Anurag Garikipati
    Dascena, Inc., Houston, TX, United States.
  • Zohora Iqbal
    Dascena, Inc., Houston, TX, United States. Electronic address: ziqbal@dascena.com.
  • Anna Siefkas
    Dascena, Inc., San Francisco, CA, USA. Electronic address: anna@dascena.com.
  • Gina Barnes
    Dascena, Inc., San Francisco, CA, USA.
  • Jana Hoffman
    Dascena Inc., San Francisco, CA, United States.
  • Qingqing Mao
    Dascena Inc., Hayward, California, USA.
  • Ritankar Das
    Dascena, Inc, Hayward, California, USA.